4D Molecular Therapeutics
FDMT
FDMT
147 hedge funds and large institutions have $1.79B invested in 4D Molecular Therapeutics in 2024 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 48 increasing their positions, 38 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
32% more funds holding
Funds holding: 111 → 147 (+36)
26% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 38
10.27% more ownership
Funds ownership: 102.93% → 113.2% (+10%)
Holders
147
Holding in Top 10
4
Calls
$24.8M
Puts
$13.2M
Top Buyers
| 1 | +$71.4M | |
| 2 | +$57.3M | |
| 3 | +$40.2M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$33.5M |
| 5 |
VA
VR Adviser
New York
|
+$31.1M |
Top Sellers
| 1 | -$59M | |
| 2 | -$50.6M | |
| 3 | -$11.6M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.43M |
| 5 |
CC
Casdin Capital
New York
|
-$7.45M |